메뉴 건너뛰기




Volumn 358, Issue 9296, 2001, Pages 1855-1863

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG; STREPTOKINASE;

EID: 0035651983     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06887-8     Document Type: Article
Times cited : (381)

References (30)
  • 3
    • 0032031688 scopus 로고    scopus 로고
    • Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: Results from the GUSTO-1 Trial
    • J Am Coll Cardiol
    • (1998) J Am Coll Cardiol , vol.31 , pp. 497-505
    • Granger, C.B.1    Becker, R.2    Tracy, R.P.3
  • 5
    • 0023258694 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge
    • Circulation
    • (1987) Circulation , vol.76 , pp. 142-154
    • Chesebro, J.H.1    Knatterud, G.2    Roberts, R.3
  • 6
    • 0030771823 scopus 로고    scopus 로고
    • Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)
    • Circulation
    • (1997) Circulation , vol.96 , pp. 2155-2161
    • White, H.D.1    Aylward, P.E.2    Frey, M.J.3
  • 7
    • 0031789077 scopus 로고    scopus 로고
    • Direct thrombin inhibition and thrombolytic therapy: Rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) Trial
    • Am J Cardiol
    • (1998) Am J Cardiol , vol.82
    • White, H.D.1
  • 8
    • 0029938993 scopus 로고    scopus 로고
    • Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I Trial
    • Circulation
    • (1996) Circulation , vol.93 , pp. 870-878
    • Granger, C.B.1    Hirsh, J.2    Califf, R.M.3
  • 10
    • 0027240597 scopus 로고
    • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
    • N Engl J Med
    • (1993) N Engl J Med , vol.329 , pp. 673-682
  • 12
    • 0028918696 scopus 로고
    • Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41 021 patients
    • Circulation
    • (1995) Circulation , vol.91 , pp. 1659-1668
    • Lee, K.L.1    Woodlief, L.H.2    Topol, E.J.3
  • 14
    • 0034711145 scopus 로고    scopus 로고
    • TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial substudy
    • Circulation
    • (2000) Circulation , vol.102 , pp. 2031-2037
    • Morrow, D.A.1    Antman, E.M.2    Charlesworth, A.3
  • 16
    • 0035949117 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
    • Lancet
    • (2001) Lancet , vol.358 , pp. 605-613
  • 17
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
    • Lancet
    • (2001) Lancet , vol.357 , pp. 1905-1914
  • 18
    • 0030879325 scopus 로고    scopus 로고
    • A comparison of reteplase with alteplase for acute myocardial infarction
    • N Engl J Med
    • (1997) N Engl J Med , vol.337 , pp. 1118-1123
  • 19
    • 0033612881 scopus 로고    scopus 로고
    • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
    • Lancet
    • (1999) Lancet , vol.354 , pp. 716-722
  • 20
    • 0029142436 scopus 로고
    • Randomised, doubleblind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): Trial to investigate equivalence
    • Lancet
    • (1995) Lancet , vol.346 , pp. 329-336
  • 23
    • 0035845674 scopus 로고    scopus 로고
    • Early reinfarction after fibrinolysis: Experience from the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Trials
    • Circulation
    • (2001) Circulation , vol.104 , pp. 1229-1235
    • Hudson, M.P.1    Granger, C.B.2    Topol, E.J.3
  • 25
    • 0034543078 scopus 로고    scopus 로고
    • Intravenous NPA for the treatment of infarcting myocardium early: InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
    • Eur Heart J
    • (2000) Eur Heart J , vol.21 , pp. 2005-2013
  • 26
    • 0027424433 scopus 로고
    • The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
    • N Engl J Med
    • (1993) N Engl J Med , vol.329 , pp. 1615-1622
  • 29
    • 0033817072 scopus 로고    scopus 로고
    • Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction: A phase II dose escalation, randomized, double-blind study
    • Eur Heart J
    • (2000) Eur Heart J , vol.21 , pp. 1530-1536
    • Ronner, E.1    Van Kesteren, H.A.2    Zijnen, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.